Literature DB >> 28859253

Flow features and device-induced blood trauma in CF-VADs under a pulsatile blood flow condition: A CFD comparative study.

Zengsheng Chen1, Sofen K Jena2, Guruprasad A Giridharan3, Steven C Koenig2,3, Mark S Slaughter2,3, Bartley P Griffith1, Zhongjun J Wu1,4.   

Abstract

In this study, the flow features and device-associated blood trauma in 4 clinical ventricular assist devices (VADs; 2 implantable axial VADs, 1 implantable centrifugal VAD, and 1 extracorporeal VAD) were computationally analyzed under clinically relevant pulsatile flow conditions. The 4 VADs were operated at fixed pump speed at a mean rate of 4.5 L/min. Mean pressure difference, wall shear stress, volume distribution of scalar shear stress (SSS), and shear-induced hemolysis index (HI) were derived from the flow field of each VAD and were compared. The computationally predicted mean pressure difference across the 3 implantable VADs was ~70 mmHg, and the extracorporeal VAD was ~345 mmHg, which matched well with their reported pressure-flow curves. The axial VADs had higher mean wall shear stress and SSS compared with the centrifugal VADs. However, the residence time of the centrifugal VADs was much longer compared with the axial VADs because of the large volume of the centrifugal VADs. The highest SSS was observed in one axial VAD, and the longest exposure time was observed in 1 centrifugal VAD. These 2 VADs generated the highest HI. The shear-induced HI varied as a function of flow rate within each cardiac cycle. At fixed pump speed, the HI was greatest at low flow rate due to longer exposure time to shear stress compared with at high flow rate. Subsequently, we hypothesize that to reduce the risk of blood trauma during VAD support, shear stress magnitude and exposure time need to be minimized.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  VAD; blood fluid dynamics; blood trauma; exposure time; scalar shear stress

Mesh:

Year:  2017        PMID: 28859253      PMCID: PMC5803368          DOI: 10.1002/cnm.2924

Source DB:  PubMed          Journal:  Int J Numer Method Biomed Eng        ISSN: 2040-7939            Impact factor:   2.747


  31 in total

1.  Long-term use of a left ventricular assist device for end-stage heart failure.

Authors:  E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

2.  Numerical simulation of an axial blood pump.

Authors:  Leok Poh Chua; Boyang Su; Tau Meng Lim; Tongming Zhou
Journal:  Artif Organs       Date:  2007-07       Impact factor: 3.094

Review 3.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

4.  Evaluation of Eulerian and Lagrangian models for hemolysis estimation.

Authors:  M Ertan Taskin; Katharine H Fraser; Tao Zhang; Changfu Wu; Bartley P Griffith; Zhongjun J Wu
Journal:  ASAIO J       Date:  2012 Jul-Aug       Impact factor: 2.872

5.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

6.  Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).

Authors:  Randall C Starling; Yoshifumi Naka; Andrew J Boyle; Gonzalo Gonzalez-Stawinski; Ranjit John; Ulrich Jorde; Stuart D Russell; John V Conte; Keith D Aaronson; Edwin C McGee; William G Cotts; David DeNofrio; Duc Thinh Pham; David J Farrar; Francis D Pagani
Journal:  J Am Coll Cardiol       Date:  2011-05-10       Impact factor: 24.094

7.  Unexpected abrupt increase in left ventricular assist device thrombosis.

Authors:  Randall C Starling; Nader Moazami; Scott C Silvestry; Gregory Ewald; Joseph G Rogers; Carmelo A Milano; J Eduardo Rame; Michael A Acker; Eugene H Blackstone; John Ehrlinger; Lucy Thuita; Maria M Mountis; Edward G Soltesz; Bruce W Lytle; Nicholas G Smedira
Journal:  N Engl J Med       Date:  2013-11-27       Impact factor: 91.245

8.  Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

9.  One-year mortality among unselected outpatients with heart failure.

Authors:  J Muntwyler; G Abetel; C Gruner; F Follath
Journal:  Eur Heart J       Date:  2002-12       Impact factor: 29.983

10.  Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system.

Authors:  O H Frazier; Timothy J Myers; Igor D Gregoric; Tehreen Khan; Reynolds Delgado; Mihai Croitoru; Kathy Miller; Robert Jarvik; Stephen Westaby
Journal:  Circulation       Date:  2002-06-18       Impact factor: 29.690

View more
  7 in total

Review 1.  Circulatory Mechanotherapeutics: Moving with the Force.

Authors:  Pablo Huang Zhang; J Yasha Kresh
Journal:  Curr Cardiol Rep       Date:  2018-08-22       Impact factor: 2.931

2.  Prediction of mechanical hemolysis in medical devices via a Lagrangian strain-based multiscale model.

Authors:  Mehdi Nikfar; Meghdad Razizadeh; Jiafeng Zhang; Ratul Paul; Zhongjun J Wu; Yaling Liu
Journal:  Artif Organs       Date:  2020-03-05       Impact factor: 3.094

3.  The impact of shear stress on device-induced platelet hemostatic dysfunction relevant to thrombosis and bleeding in mechanically assisted circulation.

Authors:  Zengsheng Chen; Jiafeng Zhang; Tieluo Li; Douglas Tran; Bartley P Griffith; Zhongjun J Wu
Journal:  Artif Organs       Date:  2019-12-17       Impact factor: 3.094

4.  Proposal of hemodynamically improved design of an axial flow blood pump for LVAD.

Authors:  Vikas Kannojiya; Arup Kumar Das; Prasanta Kumar Das
Journal:  Med Biol Eng Comput       Date:  2019-12-19       Impact factor: 2.602

5.  A New Mathematical Numerical Model to Evaluate the Risk of Thrombosis in Three Clinical Ventricular Assist Devices.

Authors:  Yuan Li; Hongyu Wang; Yifeng Xi; Anqiang Sun; Xiaoyan Deng; Zengsheng Chen; Yubo Fan
Journal:  Bioengineering (Basel)       Date:  2022-05-27

6.  Shear-Mediated Platelet Activation is Accompanied by Unique Alterations in Platelet Release of Lipids.

Authors:  Alice Sweedo; Lisa M Wise; Yana Roka-Moiia; Fernando Teran Arce; S Scott Saavedra; Jawaad Sheriff; Danny Bluestein; Marvin J Slepian; John G Purdy
Journal:  Cell Mol Bioeng       Date:  2021-08-25       Impact factor: 3.337

Review 7.  Device-Induced Hemostatic Disorders in Mechanically Assisted Circulation.

Authors:  Shigang Wang; Bartley P Griffith; Zhongjun J Wu
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.